Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Hybrigenics    ALHYG   FR0004153930


News SummaryMost relevantAll newsSector news 
Latest news on HYBRIGENICS
08/20 HYBRIGENICS : Investigators at Hybrigenics Detail Findings in Catecholamines (Ct..
04/08 HYBRIGENICS : Raises USD2.7 Million in Private Placement
04/08 HYBRIGENICS : Raises USD7.1 Million in Public Offering
02/11 HYBRIGENICS : Study Data from Hybrigenics Update Understanding of HIV/AIDS (The ..
01/27 HYBRIGENICS : Servier - Hybrigenics extends its partnership with Servier in the ..
2014 HYBRIGENICS : 2014 first-half results and highlights
2014 HYBRIGENICS : successfully raised € 4.6 million
2014 HYBRIGENICS : invests in its genomic capabilities
2014 HYBRIGENICS' : patent estate of inhibitors of ubiquitin-specific proteases is ex..
2014 HYBRIGENICS : revenus et trésorerie au premier semestre 2014
2013 HYBRIGENICS : Hybrigenics' General Meeting highlights - Focus on inecalcitol rec..
2013 HYBRIGENICS : Update on the clinical study of inecalcitol in chronic lymphocytic..
2013 HYBRIGENICS : Hybrigenics' technology platform applied to the study of the aging..
2013 HYBRIGENICS : Hybrigenics' Technology Platform Successfully Applied to the Study..
2013 HYBRIGENICS : 2012 revenues and update on the clinical study of inecalcitol in c..
2013 HYBRIGENICS : launches a new service to screen interactions between small molecu..
2012 HYBRIGENICS : green ligt for two European patents protecting new oral formulatio..
2012 HYBRIGENICS : launches a new website
2012 HYBRIGENICS : Hybrigenics' first half 2012 revenues of EUR 2 million at the same..
2012 HYBRIGENICS : Hybrigenics' General Meeting Highlights
2012 HYBRIGENICS : Bryan, Garnier & Co initiates coverage of Hybrigenics with a targe..
2012 HYBRIGENICS : Bryan Garnier initiates coverage of Hybrigenics with a target pric..
2012 HYBRIGENICS : completed its private placement to institutional investors up to E..
2012 HYBRIGENICS : gets approval and financing for a phase II clinical trial of oral ..
News chart
Full-screen chart
Income Statement Evolution
More Financials